Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$17.63 - $21.74 $497,818 - $613,872
28,237 Added 29.22%
124,878 $2.46 Million
Q4 2023

Jan 10, 2024

BUY
$14.37 - $19.07 $597,705 - $793,197
41,594 Added 75.56%
96,641 $1.7 Million
Q3 2023

Oct 27, 2023

BUY
$13.62 - $20.2 $354,147 - $525,240
26,002 Added 89.52%
55,047 $956,000
Q2 2023

Aug 09, 2023

SELL
$10.44 - $16.48 $415,887 - $656,497
-39,836 Reduced 57.83%
29,045 $409,000
Q1 2023

Apr 20, 2023

SELL
$10.7 - $15.79 $112,756 - $166,395
-10,538 Reduced 13.27%
68,881 $741,000
Q4 2022

Jan 12, 2023

BUY
$11.42 - $17.05 $114,668 - $171,199
10,041 Added 14.47%
79,419 $1.19 Million
Q3 2022

Nov 14, 2022

SELL
$9.76 - $13.41 $9,379 - $12,887
-961 Reduced 1.37%
69,378 $891,000
Q2 2022

Jul 19, 2022

SELL
$7.6 - $11.41 $7,942 - $11,923
-1,045 Reduced 1.46%
70,339 $682,000
Q1 2022

Apr 26, 2022

BUY
$9.3 - $12.37 $13,550 - $18,023
1,457 Added 2.08%
71,384 $710,000
Q4 2021

Feb 14, 2022

BUY
$10.39 - $15.15 $45,383 - $66,175
4,368 Added 6.66%
69,927 $823,000
Q3 2021

Nov 12, 2021

BUY
$11.39 - $16.23 $255,625 - $364,249
22,443 Added 52.05%
65,559 $747,000
Q2 2021

Aug 13, 2021

BUY
$13.22 - $19.09 $569,993 - $823,084
43,116 New
43,116 $601,000

Others Institutions Holding KNSA

About Kiniksa Pharmaceuticals, Ltd.


  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $732M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Hennion & Walsh Asset Management, Inc. Portfolio

Follow Hennion & Walsh Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.